BY BUG
ByBug is a biotechnology company dedicated to revolutionizing biomanufacturing through innovative use of genetically modified black soldier fly larvae. Their mission is to create the most sustainable and efficient biomanufacturing platform by transforming agro-food by-products into high-quality, cost-effective recombinant proteins and bioinputs for various industries, including pharmaceuticals, veterinary, and industrial enzymes. They aim to contribute to a circular and sustainable economy by utilizing organic waste and promoting environmental responsibility. The company collaborates with partners and has received recognition and media coverage for their innovative work in organic waste management and recombinant protein production.
Industries
Nr. of Employees
small (1-50)
BY BUG
Fifth Floor, 100 S Cincinnati Ave, Tulsa, OK 74103
Products
Cell-culture growth factor supplement
Growth factor formulation produced via engineered insect-based production intended to support cell proliferation for applications such as cultivated meat and cell lines.
Protein-based aquaculture appetite stimulant
Protein ingredient intended to increase feed efficiency in farmed fish, produced from engineered insect biomass.
Omega-3–enriched insect-derived oil
Oil with elevated omega-3 content produced by engineered insect strains, intended for use in animal nutrition and related markets.
Cell-culture growth factor supplement
Growth factor formulation produced via engineered insect-based production intended to support cell proliferation for applications such as cultivated meat and cell lines.
Protein-based aquaculture appetite stimulant
Protein ingredient intended to increase feed efficiency in farmed fish, produced from engineered insect biomass.
Omega-3–enriched insect-derived oil
Oil with elevated omega-3 content produced by engineered insect strains, intended for use in animal nutrition and related markets.
Services
End-to-end development of tailored recombinant proteins for industrial, veterinary and pharmaceutical applications, following a staged workflow from requirements to metrics.
End-to-end development of tailored recombinant proteins for industrial, veterinary and pharmaceutical applications, following a staged workflow from requirements to metrics.
Expertise Areas
- Recombinant protein production
- Insect-based biomanufacturing and bioconversion
- Bioprocess scale-up and industrialization
- Downstream processing for biologics
Key Technologies
- Genetic engineering
- Synthetic biology
- Insect-based bioreactors
- Bioconversion of organic waste
News & Updates
ByBug's expansion and scaling efforts in Tulsa, featuring co-founder Gerardo Bluske.
Recognition for using insects to transform organic waste, finalist in Premios Avonni.
Webinar discussing the company's journey in securing seed funding.
Article on cost-effective and scalable recombinant protein production using black soldier fly.
Coverage of ByBug's fundraising success in Coquimbo.
News about ByBug closing a new investment round of 1.4 million USD.
ByBug's expansion and scaling efforts in Tulsa, featuring co-founder Gerardo Bluske.
Recognition for using insects to transform organic waste, finalist in Premios Avonni.
Webinar discussing the company's journey in securing seed funding.
Article on cost-effective and scalable recombinant protein production using black soldier fly.
Coverage of ByBug's fundraising success in Coquimbo.
News about ByBug closing a new investment round of 1.4 million USD.